A dose-reduction HPV vaccine immunobridging trial of two HPV vaccines among adolescent girls in Tanzania (the DoRIS trial) – Study protocol for a randomised controlled trial-Reference-Cited by-同舟云学术

A dose-reduction HPV vaccine immunobridging trial of two HPV vaccines among adolescent girls in Tanzania (the DoRIS trial) – Study protocol for a randomised controlled trial

Published:2021-02 Issue: Volume:101 Page:106266
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Baisley Kathy J.,Whitworth Hilary S.,Changalucha John,Pinto Ligia,Dillner Joakim,Kapiga Saidi,de Sanjosé Silvia,Mayaud Philippe,Hayes Richard J.,Lacey Charles J.,Watson-Jones Deborah

Funder

Bill and Melinda Gates Foundation

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference30 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Meeting of the Strategic Advisory Group of Experts on immunization, April 2014 -- conclusions and recommendations;World Health Organization;Wkly Epidemiol. Rec.,2014

3. Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania;Quentin;BMC Med.,2012

4. Delivery cost of human papillomavirus vaccination of young adolescent girls in Peru, Uganda and Viet Nam;Levin;Bull. World Health Organ.,2013

5. HPV-FASTER: broadening the scope for prevention of HPV-related cancer;Bosch;Nat. Rev. Clin. Oncol.,2016

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness of Human Papillomavirus Vaccination in the UK: Two Versus Single-Dose of Nonavalent HPV Vaccination;American Journal of Preventive Medicine;2024-08

2. The deadlock on HPV vaccination in Japan is almost broken!;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-06

3. Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose in young women aged 15–20 years in Kenya (KEN SHE): an immunobridging analysis of randomised controlled trials;The Lancet Global Health;2024-03

4. Durability of Immunogenicity at 5 Years after a Single Dose of HPV Vaccine Compared with 2 Doses in Tanzanian Girls Aged 9-14 Years:  Results of the Long-Term Extension of the DoRIS Randomised Trial;2024

5. Estimating human papillomavirus vaccine efficacy from a single-arm trial: proof-of-principle in the Costa Rica Vaccine Trial;JNCI: Journal of the National Cancer Institute;2023-04-11